Form 4: Braze Inc. Executive Myles Kleeger Sells Shares
SEC Form 4 Filing
Myles Kleeger, President & CCO of Braze Inc., recently sold shares of Class A Common Stock to cover tax obligations and under a pre-arranged trading plan.
Summary
- Myles Kleeger, the President & CCO of Braze, Inc. (BRZE), reported the sale of company stock.
- On August 16, 2024, Kleeger sold 9,178 shares of Class A Common Stock at a price of $41.37 per share to cover tax obligations related to vesting restricted stock units.
- On August 20, 2024, Kleeger sold 6,377 shares of Class A Common Stock at a weighted average price of $43.58 per share, under a Rule 10b5-1 trading plan adopted on December 29, 2023.
- Following these transactions, Kleeger directly owns 199,963 shares of Class A Common Stock, including 195,594 shares represented by restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock sales by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence and are often related to personal financial planning or tax obligations. The use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on inside information.
Key Dates
| Date | Description |
|---|---|
| November 16, 2021 | Date of implementation of the non-discretionary sell-to-cover program. |
| April 30, 2023 | Date of last modification to the non-discretionary sell-to-cover program. |
| December 29, 2023 | Date of adoption of the Rule 10b5-1 trading plan. |
| August 16, 2024 | Date of first reported stock sale. |
| August 20, 2024 | Date of second reported stock sale. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.